Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:14619492rdf:typepubmed:Citationlld:pubmed
pubmed-article:14619492lifeskim:mentionsumls-concept:C0007113lld:lifeskim
pubmed-article:14619492lifeskim:mentionsumls-concept:C0153676lld:lifeskim
pubmed-article:14619492lifeskim:mentionsumls-concept:C0442027lld:lifeskim
pubmed-article:14619492lifeskim:mentionsumls-concept:C0016360lld:lifeskim
pubmed-article:14619492lifeskim:mentionsumls-concept:C0574032lld:lifeskim
pubmed-article:14619492lifeskim:mentionsumls-concept:C1420361lld:lifeskim
pubmed-article:14619492lifeskim:mentionsumls-concept:C1545922lld:lifeskim
pubmed-article:14619492lifeskim:mentionsumls-concept:C1446539lld:lifeskim
pubmed-article:14619492lifeskim:mentionsumls-concept:C0205195lld:lifeskim
pubmed-article:14619492lifeskim:mentionsumls-concept:C1533148lld:lifeskim
pubmed-article:14619492lifeskim:mentionsumls-concept:C1524063lld:lifeskim
pubmed-article:14619492lifeskim:mentionsumls-concept:C2003874lld:lifeskim
pubmed-article:14619492pubmed:issue11lld:pubmed
pubmed-article:14619492pubmed:dateCreated2003-11-17lld:pubmed
pubmed-article:14619492pubmed:abstractTextWe have studied the pharmacokinetics of 5-FU hepato-arterial infusion (HAI) with combined use of oral UFT for colorectal cancer cases previously. The plasma 5-FU concentration in cases of 5-FU HAI plus UFT is 1.5-6 times as high as with 5-FU HAI only. We report a rectal cancer case with liver and lung metastases treated successfully with this protocol. A 75-year-male underwent low anterior resection for rectal cancer as Rab, 3.5 x 3 cm, well, ai, n2, P0, H3, M1 on March 26, 2002. For synchronous hepatic and lung metastases, he received weekly 5-FU 1,000 mg HAI, UFT 4T 2 x postoperatively. As a result, liver and lung metastases disappeared over 6 months. We recommend weekly 5-FU HAI with combined use of UFT, which can be more effective not only for liver metastases but also for extra-hepatic lesion of colorectal cancer.lld:pubmed
pubmed-article:14619492pubmed:languagejpnlld:pubmed
pubmed-article:14619492pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14619492pubmed:citationSubsetIMlld:pubmed
pubmed-article:14619492pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14619492pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14619492pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14619492pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14619492pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14619492pubmed:statusMEDLINElld:pubmed
pubmed-article:14619492pubmed:monthOctlld:pubmed
pubmed-article:14619492pubmed:issn0385-0684lld:pubmed
pubmed-article:14619492pubmed:authorpubmed-author:NagahamaTakes...lld:pubmed
pubmed-article:14619492pubmed:authorpubmed-author:MaruyamaMichi...lld:pubmed
pubmed-article:14619492pubmed:authorpubmed-author:EbuchiMasakaz...lld:pubmed
pubmed-article:14619492pubmed:authorpubmed-author:HasegawaKumiKlld:pubmed
pubmed-article:14619492pubmed:authorpubmed-author:TakashimaItar...lld:pubmed
pubmed-article:14619492pubmed:authorpubmed-author:ShinouraHiros...lld:pubmed
pubmed-article:14619492pubmed:authorpubmed-author:KatoKiyomiKlld:pubmed
pubmed-article:14619492pubmed:issnTypePrintlld:pubmed
pubmed-article:14619492pubmed:volume30lld:pubmed
pubmed-article:14619492pubmed:ownerNLMlld:pubmed
pubmed-article:14619492pubmed:authorsCompleteYlld:pubmed
pubmed-article:14619492pubmed:pagination1678-81lld:pubmed
pubmed-article:14619492pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:14619492pubmed:meshHeadingpubmed-meshheading:14619492...lld:pubmed
pubmed-article:14619492pubmed:meshHeadingpubmed-meshheading:14619492...lld:pubmed
pubmed-article:14619492pubmed:meshHeadingpubmed-meshheading:14619492...lld:pubmed
pubmed-article:14619492pubmed:meshHeadingpubmed-meshheading:14619492...lld:pubmed
pubmed-article:14619492pubmed:meshHeadingpubmed-meshheading:14619492...lld:pubmed
pubmed-article:14619492pubmed:meshHeadingpubmed-meshheading:14619492...lld:pubmed
pubmed-article:14619492pubmed:meshHeadingpubmed-meshheading:14619492...lld:pubmed
pubmed-article:14619492pubmed:meshHeadingpubmed-meshheading:14619492...lld:pubmed
pubmed-article:14619492pubmed:meshHeadingpubmed-meshheading:14619492...lld:pubmed
pubmed-article:14619492pubmed:meshHeadingpubmed-meshheading:14619492...lld:pubmed
pubmed-article:14619492pubmed:meshHeadingpubmed-meshheading:14619492...lld:pubmed
pubmed-article:14619492pubmed:meshHeadingpubmed-meshheading:14619492...lld:pubmed
pubmed-article:14619492pubmed:meshHeadingpubmed-meshheading:14619492...lld:pubmed
pubmed-article:14619492pubmed:meshHeadingpubmed-meshheading:14619492...lld:pubmed
pubmed-article:14619492pubmed:meshHeadingpubmed-meshheading:14619492...lld:pubmed
pubmed-article:14619492pubmed:year2003lld:pubmed
pubmed-article:14619492pubmed:articleTitle[A case of liver and lung metastases of rectal cancer responding well to 5-FU hepato-arterial infusion (HAI) with combined use of oral UFT].lld:pubmed
pubmed-article:14619492pubmed:affiliationDept. of Surgery, Tokyo Metropolitan Ohkubo Hospital.lld:pubmed
pubmed-article:14619492pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:14619492pubmed:publicationTypeEnglish Abstractlld:pubmed
pubmed-article:14619492pubmed:publicationTypeCase Reportslld:pubmed